FIGURE 5.
Polyion complex micelle (PIC/m)‐TMPO‐AS1 siRNA treatment suppresses s.c. triple‐negative breast cancer tumor growth. A, B, Progression of MDA‐MB‐231‐derived xenograft tumors treated with PIC/m loaded with siRNAs (PIC/m‐siRNA) in nude mice. PIC/m‐negative control siRNA (siControl) or PIC/m‐siTMPO‐AS1 #2 were i.v. injected into mice inoculated with MDA‐MB‐231 cells through tail veins twice a week (PIC/m‐siControl, n = 5; PIC/m‐siTMPO‐AS1 #2, n = 6). Tumor volumes are presented as mean ± SE (A). Representative photographs of xenografted mice are shown (B). C, TMPO‐AS1, ESR1, MCM6, MAD2L1, CHEK1, TGFBR1, and TGFBR2 levels in tumors treated with PIC/m‐siControl or PIC/m‐siTMPO‐AS #2. Tumors were dissected from mice 60 days after the beginning of siRNA administration. Data are presented as mean fold change ± SD vs siControl (n = 3). *P < .05; **P < .01; ***P < .001